Dexchlorpheniramine Maleate
1 NDC across 1 manufacturer|0 Generic,1 Brand
Dexchlorpheniramine Maleate is used to treat angioedema, allergic conjunctivitis, rhinitis, allergic, perennial, rhinitis, allergic, seasonal and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
▸ More about this market▾ Less
The brand product the first generic was approved Jan 1, 1982. In 2024, Medicare Part D spent $52K on Dexchlorpheniramine Maleate across 84 claims for 35 beneficiaries.
Dexchlorpheniramine Maleate is available as 1 NDC from 1 manufacturer (0 generic, 1 brand), with NADAC prices from $2.90 to $2.90 per ML. Every pack size and labeler in this drug market is compared side-by-side below.
Total NDCs
1
0G / 1B
Manufacturers
1
competing in market
Price Spread
$2.90 – $2.90
per ML
7d Activity
avg +0.0% WoW · of 1 NDCs
Market Price Trend
Monthly average NADAC per unit, split by generic and brand.
Explore this market from other angles
Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.
Top supplier
CARWIN PHARMACEUTICAL ASSOCIATES, LLC manufacturer profile
Open the supplier page for the manufacturer with the strongest footprint in this market.
Trend hub
Latest market trends
Move from this single molecule into the current cross-market mover and volatility view.
Guide
How to interpret NADAC
Review the benchmark methodology behind the prices and spreads shown on this market page.
Manufacturer Breakdown
1 manufacturer producing DEXCHLORPHENIRAMINE MALEATE
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
RYCLORA 2 MG/5 ML SOLUTION | $2.9021 per ML | — |
Frequently Asked Questions
What is Dexchlorpheniramine Maleate used to treat?
Dexchlorpheniramine Maleate is used to treat angioedema, allergic conjunctivitis, rhinitis, allergic, perennial, rhinitis, allergic, seasonal and vasomotor rhinitis, per the National Library of Medicine's MED-RT classification.
When did Dexchlorpheniramine Maleate become available as a generic?
FDA approved the first generic Dexchlorpheniramine Maleate (ANDA) on Jan 1, 1982.
How much does Medicare spend on Dexchlorpheniramine Maleate?
In 2024, Medicare Part D spent $52K on Dexchlorpheniramine Maleate across 84 claims for 35 beneficiaries.
How many Dexchlorpheniramine Maleate products are on the market?
The Dexchlorpheniramine Maleate drug market contains 1 NDC from 1 manufacturer — 0 generic and 1 brand product.
What is the price range for Dexchlorpheniramine Maleate?
NADAC reference prices for Dexchlorpheniramine Maleate range from $2.9021 to $2.9021 per ML.
Which manufacturers make Dexchlorpheniramine Maleate?
1 manufacturer lists Dexchlorpheniramine Maleate in NADAC. Ranked by number of NDCs, the largest are CARWIN PHARMACEUTICAL ASSOCIATES, LLC (1).